Information presented is for educational purposes and reflects clinical observations under the medical oversight of Dr. Igor I. Bussel, MD. Wolverine Stack advocates for physician-monitored protocols only. Not evaluated by the FDA. Compliant with CSC/CanG educational directives.

321 peer-reviewed protocols analyzed. 14 ongoing clinical outcome monitors.

Peptide Intelligence for Tissue Repair.

The evidence-first hub for the most effective regenerative stack in clinical use: BPC-157 and TB-500. Zero hype. Pure data.

View the Definitive Guide Verify Clinic Partners

Active Components

BPC-157 & TB-500

Evidence Grade

B+

Evidence Tracker

We aggregate clinical data, animal studies, and mechanistic theories to grade the efficacy of recovery peptides.

Mechanism
Evidence Level
Primary Source
Status
Tier 1 (Extensive In-Vivo)
PubMed ID: 29898649
Last Updated: 12 Oct 2024 Access Full Library →

Components of the Stack

BPC-157

Body Protection Compound

A synthetic 15-amino acid sequence isolated from gastric juice, demonstrating profound systemic healing effects across tendon, ligament, and gastrointestinal tissues. Backed by three decades of safety data.

View Full Dossier

TB-500

Thymosin Beta-4 Fragment

The synthetic fraction of Thymosin Beta-4 responsible for rapid cellular migration and tissue regeneration. Synergizes with BPC-157 to accelerate the repair phase of acute muscular and connective injuries.

View Full Dossier
Dr. Bussel
Verified MD

Medical Review & Policy

"All protocols and evidence frameworks are medically reviewed by Dr. Igor I. Bussel, MD, ensuring clinical accuracy and patient safety. 100% of listed clinics verified for compounding compliance and physician oversight."

Board Certified

Igor I. Bussel, MD

Last Review

Q4 2024

Frequently Queried

Pillar Guide Ingredients Research Safety
Clinic Consult